CAS: 1628260-79-6 - GLPG-1690
![5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-…](https://static.cymitquimica.com/products/IN/thumb/DA001TG5.jpg)
5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-
CAS:1628260-79-6
Formula:
C30H33FN8O2S
Purity:
%
Color and Shape:
Solid
Molecular weight:
588.6988
Ref: IN-DA001TG5
| 5mg | 63.00 € | ||
| 10mg | 81.00 € | ||
| 25mg | 117.00 € | ||
| 50mg | 168.00 € | ||
| 100mg | 238.00 € | ||
| 250mg | 522.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ziritaxestat
CAS:1628260-79-6
Ziritaxestat (GLPG1690), an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in …
Formula:
C30H33FN8O2S
Purity:
97% - 99.67%
Color and Shape:
Solid
Molecular weight:
588.7
Ref: TM-T4041
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 119.00 € | ||
| 50mg | 186.00 € | ||
| 100mg | 347.00 € | ||
| 200mg | 515.00 € | ||
| 1mL*10mM (DMSO) | 61.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
GLPG1690
Controlled ProductCAS:1628260-79-6
Applications GLPG1690 is a selective autotaxin inhibitor discovered by Galapagos, with potential application in idiopathic …
Formula:
C30H33FN8O2S
Color and Shape:
Neat
Molecular weight:
588.699
Ref: TR-G411813
| 5mg | 168.00 € | ||
| 10mg | 291.00 € | ||
| 25mg | 535.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
GLPG1690
CAS:1628260-79-6
GLPG1690 is a potent, selective, and orally active small molecule that inhibits the signal transduction …
Formula:
C30H33FN8O2S
Purity:
Min. 95%
Molecular weight:
588.7 g/mol
Ref: 3D-DQC26079
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
